Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • Army Medical College Jashore | MBBS Admission Open for Foreign Students with Fortune Education
    Army Medical College Jashore | MBBS Admission Open for Foreign Students with Fortune Education Business
  • Aronora Announces Clinical Data to Be Presented at the 64th American Society of Hematology Annual Meeting
    Aronora Announces Clinical Data to Be Presented at the 64th American Society of Hematology Annual Meeting Business
  • Secretary Antony J. Blinken And Nigerien Foreign Minister Hassoumi Massoudou at a Joint Press Availability
    Secretary Antony J. Blinken And Nigerien Foreign Minister Hassoumi Massoudou at a Joint Press Availability World News
  • AIM Enterprises Expands Inventory to Include Top-Quality Used Picture Framing Equipment
    AIM Enterprises Expands Inventory to Include Top-Quality Used Picture Framing Equipment Business
  • VDO.AI’s Innovative Technology-Led Campaign for The NBA Earns Shortlist at The Drum Awards for Marketing Americas 2023
    VDO.AI’s Innovative Technology-Led Campaign for The NBA Earns Shortlist at The Drum Awards for Marketing Americas 2023 World News
  • ComplianceQuest Introduces Safety Essentials, an AI-Powered Safety Management Solution for Small to Mid-Size Businesses
    ComplianceQuest Introduces Safety Essentials, an AI-Powered Safety Management Solution for Small to Mid-Size Businesses Business
  • A Call to Action for Mental Health Awareness
    A Call to Action for Mental Health Awareness World News
  • War Day 296: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    War Day 296: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
GB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in China

GB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in China

Posted on March 20, 2023 By NewsEditor
GB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in ChinaGB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in ChinaAccording to Statista, China has the second largest pharmaceutical market in the world and plant-based medicines are very well accepted, which makes China a potential target market for Gb Sciences.

GB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in China
Patent


LAS VEGAS, March 20, 2023 (Newswire.com) - Gb Sciences, Inc. (OTCQB:GBLX), a leading cannabis- and plant-inspired biopharmaceutical research and development company, has recently been issued a patent in China to protect its proprietary cannabinoid-containing formulation for the treatment of Parkinson's disease. China is an increasingly important pharmaceutical market with cultural acceptance of plant-based formulations, which is a good fit for Gb Sciences' drug candidates. Gb Sciences' first international patent also confirms that the Company's intellectual property strategy can work globally and strengthens the Company's patent portfolio. The global market for treatments of Parkinson's disease is projected to grow to $8.8 billion by the year 2026, and new therapies to address Parkinson's disease symptoms are greatly needed.

"The issuance of Gb Sciences' first international patent protecting methods of using our proprietary cannabinoid-containing formulations for treating Parkinson's disease is an important milestone in the development of these vitally important therapies. Gb Sciences' recent patent issued in China validates both our plant-inspired drug discovery process and intellectual property strategy, which involve defining and protecting Minimum Essential Mixtures," explained Dr. Andrea Small-Howard, President and Chief Science Officer of Gb Sciences, Inc. "Gb Sciences starts its drug discovery process with plant-based therapies that are working anecdotally or in traditional medical systems, then we systematically reduce the number of compounds to reveal Minimum Essential Mixtures. Gb Sciences' novel Minimum Essential Mixtures retain the increased efficacy of whole plant medicines, but they are easier to manufacture with precision at scale like single ingredient drugs. These Minimum Essential Mixtures are a viable alternative to standard single ingredient drugs or traditional whole plant medicines."

Gb Sciences' Minimum Essential Mixture-based drug development strategy does not aim to treat complex diseases as if they were caused by a single factor, but instead addresses the combination of factors that lead to a complex human disorder. Minimum Essential Mixtures (MEMs) are potentially more effective than single ingredient drugs because the different active ingredients target the multiple human processes responsible for complex diseases, such as neurodegeneration, heart disease, and cancers. As such, MEMs may offer a more holistic treatment for complex disorders such as Parkinson's disease that cannot be attributed to a single cause, while maintaining the manufacturing and quality control advantages of single ingredient drugs.

Gb Sciences' patent portfolio currently contains six issued U.S. and four issued foreign patents, as well as 15 U.S. and 49 foreign patent-pending applications that cover our novel AI-enabled drug discovery platform and proprietary plant-inspired therapies for more than 65 different disorders. 

To learn more about Gb Sciences, visit www.gbsciences.com.

About Gb Sciences and GbS Global Biopharma

Gb Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company creating patented, disease-targeted formulations of cannabis- and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. The 'plant-inspired' active ingredients in its therapeutic mixtures are synthetic homologues identical to the original plant compounds but produced under current Good Manufacturing Practices. Gb Sciences' intellectual property portfolio contains six issued U.S. and four issued foreign patents, as well as 15 U.S. and 49 foreign patent-pending applications. In its drug development pipeline, Gb Sciences has five preclinical phase product development programs. Gb Sciences' lead program for Parkinson's disease is being prepared for a first-in-human clinical trial. Gb Sciences' formulations for chronic pain, anxiety and depression are currently in preclinical animal studies with researchers at the National Research Council of Canada (NRC). The company also received positive preclinical proof-of-concept data supporting its complex mixtures for the treatment of Cytokine Release Syndrome, and its lead candidates will be optimized based on late-stage preclinical studies at Michigan State University. Gb Sciences' productive research and development network includes distinguished universities, hospitals, and Contract Research Organizations. To learn more, visit www.gbsciences.com.

Forward-Looking Statements

This press release may contain statements relating to future results or events, which are forward-looking statements. Words such as "expects," "intends," "plans," "may," "could," "should," "anticipates," "likely," "believes" and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company's belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company's control. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further, information concerning the Company and its business, including factors that potentially could materially affect the Company's business and financial and other results, are contained in the Company's filings with the Securities and Exchange Commission, available at www.sec.gov. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.

Contact Information:
Alexis Quintal
[email protected]


Original Source: GB Sciences' First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson's Disease Has Been Issued in China

The post GB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in China first appeared on Social Gov.

Business

Post navigation

Previous Post: War Day 220: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
Next Post: War Day 219: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin

Related Posts

  • Modern Classic by Cheng Seok Hwa Wins Iron in A’ Interior Design Awards
    Modern Classic by Cheng Seok Hwa Wins Iron in A’ Interior Design Awards Business
  • TV Ears Achieves A+ Rating From BBB
    TV Ears Achieves A+ Rating From BBB Business
  • Mvix Launches a Device-Agnostic, Visual Communication Platform for Hybrid Workforce and Remote Audience
    Mvix Launches a Device-Agnostic, Visual Communication Platform for Hybrid Workforce and Remote Audience Business
  • Capitalize: 6 Mistakes People Make When They Start a New Job
    Capitalize: 6 Mistakes People Make When They Start a New Job Business
  • Crypto Exchange BTSE to Apply for Hong Kong Digital Asset Licenses
    Crypto Exchange BTSE to Apply for Hong Kong Digital Asset Licenses Business
  • Investor Fears Spike as Mongolia Enacts Law Targeting Private Sector
    Investor Fears Spike as Mongolia Enacts Law Targeting Private Sector Business
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
« Aug    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • INDIAN SUPREME COURT SIT GIVES VANTARA A CLEAN CHIT, CONFIRMS FULL REGULATORY COMPLIANCESeptember 17, 2025
  • A Decade Defined by Financial Fragmentation, Ubiquitous Touchpoints, and the Great Wealth TransferSeptember 17, 2025
  • War in Ukraine, Analytics. Day 1285: Putin, Modi and Xi Meeting in China. Arestovych, Shelest.September 16, 2025
  • Attorney John Williams Joins Missouri Criminal Defense Firm Combs WaterkotteSeptember 16, 2025
  • Amy Shira Teitel, Space Historian and Author, Weighs In on NASA’s Moon Race: Safety Can’t Be SacrificedSeptember 16, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Marcus Smart Partners With Signd Creating a Unique Memorabilia Experience for Celtic Fans
    Marcus Smart Partners With Signd Creating a Unique Memorabilia Experience for Celtic Fans Business
  • Strong Growth Predicted for Multivalent Vaccines Global Market, Set to Reach .16 Billion by 2028
    Strong Growth Predicted for Multivalent Vaccines Global Market, Set to Reach $12.16 Billion by 2028 Business
  • 40+ HighSchoolers completed Civic Engagement & Leadership Program from Foundation for India and Indian Diaspora Studies
    40+ HighSchoolers completed Civic Engagement & Leadership Program from Foundation for India and Indian Diaspora Studies World News
  • POW call gone wrong –  Volodymyr Zolkin
    POW call gone wrong – Volodymyr Zolkin World News
  • Sherwood Lumber Announces 5-Day-a-Week Service to MA, CT, RI, and Albany: Doubling Down on Its Promise of ‘We’ll Be There’
    Sherwood Lumber Announces 5-Day-a-Week Service to MA, CT, RI, and Albany: Doubling Down on Its Promise of ‘We’ll Be There’ Business
  • Assistant Secretary for International Narcotics and Law Enforcement Affairs Robinson Travels to Tbilisi, Rome, Vatican City, and Vienna
    Assistant Secretary for International Narcotics and Law Enforcement Affairs Robinson Travels to Tbilisi, Rome, Vatican City, and Vienna World News
  • Apostle Leina’ala Mars-Opoku Receives Biden’s Gold Lifetime Achievement Award
    Apostle Leina’ala Mars-Opoku Receives Biden’s Gold Lifetime Achievement Award World News
  • ChinaAMC wins two titles for excellence in asset management and sustainable investment
    ChinaAMC wins two titles for excellence in asset management and sustainable investment World News
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .